{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:31:46Z","timestamp":1777329106234,"version":"3.51.4"},"reference-count":0,"publisher":"Portico","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2019.55.9.3020160","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T12:17:36Z","timestamp":1569845856000},"page":"545","source":"Crossref","is-referenced-by-count":11,"title":["Glasdegib for the treatment of adult patients with newly diagnosed\nacute myeloid leukemia or high-grade myelodysplastic syndrome who\nare elderly or otherwise unfit for standard induction chemotherapy"],"prefix":"10.3730","volume":"55","author":[{"family":"Goldsmith, S.R.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lovell, A.R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Schroeder, M.A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2019]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:43:32Z","timestamp":1685454212000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddf4p5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2019.55.9.3020160","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}